ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC.

Karlijn Hummelink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.